Charles Cobb | Dentistry | Excellence in Research

Posted on by ScienceFather

Dr. Charles Cobb | Dentistry | Excellence in Research

Professor Emeritus at University of Missouri-Kansas City, United States

Dr. Charles M. Cobb, D.D.S., M.S., Ph.D., is a Professor Emeritus in the Department of Periodontics at the University of Missouri-Kansas City School of Dentistry. With over five decades of academic, clinical, and research experience, Dr. Cobb has established himself as a leading expert in periodontics and related fields. His interdisciplinary training, which spans dentistry, microbiology, anatomy, and cell biology, underscores his broad expertise. A dedicated educator and researcher, Dr. Cobb has contributed significantly to advancing periodontal sciences through teaching, mentorship, and scholarly work. His career includes leadership roles in developing advanced academic programs and shaping the next generation of periodontists. He has also practiced clinically, providing comprehensive periodontal care alongside his academic endeavors.

Professional Profile

Education

Dr. Cobb’s academic credentials reflect a commitment to excellence and interdisciplinary study. He earned his Doctor of Dental Surgery (D.D.S.) from the University of Missouri-Kansas City in 1964, followed by a Certificate in Periodontics and a Master of Science in Microbiology in 1966. He further pursued a Ph.D. in Anatomy, with a specialization in Microanatomy and Cell Biology, from Georgetown University in 1971. In addition to his formal degrees, Dr. Cobb completed military training programs, including courses at the U.S. Navy Officer Candidate School and the National Defense University, further enhancing his leadership and organizational skills.

Professional Experience

Dr. Cobb’s professional career encompasses a diverse range of roles in academia, clinical practice, and administration. He began his career in the U.S. Navy Dental Corps, where he served as Director of Courses in Mass Casualty Triage and Combat First Aid. He has held academic positions at institutions such as Louisiana State University, the University of Alabama in Birmingham, and the University of Missouri-Kansas City (UMKC). At UMKC, Dr. Cobb advanced through the ranks to become Professor of Periodontics and Oral Biology and later Professor Emeritus. He has also maintained private periodontal practices, balancing clinical excellence with academic commitments. His leadership roles include serving as Interim Director of Graduate Periodontics at UMKC.

Research Interests

Dr. Cobb’s research interests lie at the intersection of periodontics, implantology, and oral biology. He has explored the ultrastructural biology of the periodontium, microbiology of periodontal diseases, and bone physiology, particularly in the context of dental implant integration and peri-implant diseases. His work includes studies on bone formation, osseointegration, and the cellular and microbial dynamics of periodontal tissues. Dr. Cobb’s interdisciplinary approach integrates anatomy, microbiology, and clinical periodontics, making his research highly relevant to advancing both fundamental knowledge and practical applications in periodontal care.

Research Skills

Dr. Cobb possesses a robust set of research skills that have driven his academic and clinical contributions. He is proficient in histological and histochemical techniques, with expertise in microanatomy and cell biology. His work has involved advanced microscopy, microbial analysis, and experimental design for studying periodontal and implant-related conditions. Dr. Cobb has also demonstrated leadership in coordinating research projects, mentoring graduate students, and integrating research findings into clinical practice. His ability to translate complex scientific concepts into practical applications underscores his effectiveness as a researcher and educator.

Awards and Honors

Dr. Cobb has been recognized for his significant contributions to periodontics and dental education. He achieved Diplomate status with the American Board of Periodontology, maintaining recertifications throughout his career until his retirement. His tenure as Professor Emeritus at UMKC reflects his long-standing impact on the academic community. Additionally, his service in the U.S. Navy and his academic leadership roles further highlight his commitment to excellence and professional integrity. Dr. Cobb’s awards and honors underscore his dedication to advancing periodontal science and education.

Conclusion

Dr. Charles M. Cobb’s distinguished career exemplifies a lifetime commitment to excellence in periodontics, education, and research. His interdisciplinary expertise, spanning microbiology, anatomy, and clinical periodontics, has contributed to advancing knowledge and improving clinical outcomes. As an educator, he has shaped the careers of countless dental professionals through innovative teaching and mentorship. His research has addressed critical challenges in periodontal and implant sciences

Publication Top Notes

  1. Perigraftitis and implant therapy: A case report
    • Authors: Do, J.H., Cobb, C.M.
    • Year: 2024
  2. The need for updated treatment- and outcomes-based guidelines for periodontal therapy
    • Authors: Harrel, S.K., Cobb, C.M.
    • Year: 2024
  3. Calculus: A risk factor for failed periodontal therapy
    • Authors: Harrel, S.K., Cobb, C.M.
    • Year: 2024
    • Citations: 1
  4. Development of Root Caries Associated with the Use of Sugar-Free Nicotine Lozenges: A Long-Term Case Report
    • Authors: Ehrhardt, C., Mäkinen, K.K., Cobb, C.M.
    • Year: 2024
  5. Laser and scanning electron microscopy evaluation of residual microislands of calculus
    • Authors: Harrel, S.K., Cobb, C.M., Nunn, M.E., Zhao, D.
    • Year: 2024
  6. A randomized double-blind clinical trial evaluating comparative plaque and gingival health associated with commercially available stannous fluoride-containing dentifrices as compared to a sodium fluoride control dentifrice
    • Authors: Geisinger, M.L., Geurs, N.C., Novy, B., Takesh, T., Wilder-Smith, P.
    • Year: 2023
    • Citations: 2
  7. Authors’ Response
    • Authors: Harrel, S.K., Rethman, M.P., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2023
  8. When is periodontal maintenance not enough?: The need for clinical guidance
    • Authors: Harrel, S.K., Rethman, M.P., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2023
  9. Effect of EDTA Gel on Residual Subgingival Calculus and Biofilm: An In Vitro Pilot Study
    • Authors: Cobb, C.M., Harrel, S.K., Zhao, D., Spencer, P.
    • Year: 2023
    • Citations: 4
  10. Commentary Letters
    • Authors: Rethman, M.P., Harrel, S.K., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2022

 

 

Rumi Ueha | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Rumi Ueha | Medicine and Dentistry | Best Researcher Award

Director at Swallowing Center/The University of Tokyo Hospital, Japan

Dr. Rumi Ueha is a distinguished specialist in otolaryngology, focusing on airway surgery, swallowing disorders, and olfactory disorders. Holding both an M.D. and Ph.D., Dr. Ueha has accumulated significant expertise through her academic and clinical career. She has contributed extensively to the medical field, particularly in research concerning dysphagia, pediatric airway, chronic airway inflammation, and the regeneration of olfactory receptor cells. Dr. Ueha’s leadership is evident through her current position as Director and Associate Professor at the University of Tokyo, where she combines research, clinical practice, and mentorship. She is internationally recognized for her research in swallowing surgery and airway management, frequently collaborating with institutions across Japan and globally.

Professional Profile

Education:

Dr. Ueha earned her M.D. from the University of Tokyo in 2003, followed by her Ph.D. in 2017, also from the University of Tokyo. Her educational journey includes extensive training in otolaryngology and head and neck surgery, with specialized fellowships in broncho-esophagology. She has studied at renowned institutions, such as the University of California, Davis, and the University of Michigan, further solidifying her academic foundation. This rigorous education laid the groundwork for her research into complex disorders involving the airway, swallowing, and olfaction.

Professional Experience:

Dr. Ueha’s professional journey spans various prestigious roles, beginning as a resident and fellow in otolaryngology at the University of Tokyo and NTT Medical Center. Over the years, she advanced through key positions such as Assistant Professor and Project Lecturer, before being appointed as Director and Associate Professor. Her clinical and research work at the Swallowing Center of the University of Tokyo Hospital has contributed to groundbreaking advancements in dysphagia and swallowing surgery. She has also held visiting researcher roles, expanding her global network and research opportunities.

Research Interests:

Dr. Ueha’s research primarily focuses on the medical and surgical management of swallowing disorders (dysphagia), airway surgery, and olfactory disorders. She is particularly interested in swallowing surgery, chronic airway inflammation, and esophageal dysmotility. Dr. Ueha has explored innovative approaches in airway virtual reality, voice surgery, and pediatric airway management. Additionally, her work in olfactory receptor cell regeneration and the effects of aging on the olfactory system highlights her commitment to advancing treatment options for patients with sensory impairments. Her research also investigates the impact of SARS-CoV-2 on these systems.

Research Skills:

Dr. Ueha’s research skills are broad and multidisciplinary, combining clinical expertise with innovative technologies. She has demonstrated advanced knowledge in airway surgery, swallowing rehabilitation, and neurophysiology. Her skills also extend to virtual reality applications for airway management, showing her adaptability to emerging technologies. Dr. Ueha excels in clinical trials, with a focus on neuromuscular diseases and their impact on swallowing. Her ability to conduct translational research that bridges laboratory findings with clinical applications has led to advancements in treating complex airway and swallowing conditions.

Awards and Honors:

Dr. Ueha has received numerous prestigious awards in recognition of her contributions to otolaryngology and research. These include the Woman Award 2024 by the Oto-Rhino-Laryngological Society of Japan and the Excellence Award at the 16th Scientific Meeting of the Japanese Society of Anti-Aging Medicine. She has also been honored with several first-place prizes, including those for her management improvement projects at the University of Tokyo Hospital. Her recognition in the academic community extends to multiple journal editorial board positions, including for Auris Nasus Larynx and the Japanese Journal of Rhinology, where she influences advancements in her field.

Conclusion:

Dr. Rumi Ueha is a highly accomplished researcher and academic leader in the field of otolaryngology, particularly in swallowing disorders and airway surgery. Her strong academic background, multiple accolades, and extensive international experience make her an outstanding candidate for the Best Researcher Award. While further efforts in research funding and interdisciplinary collaborations would elevate her work, her substantial contributions to her field position her as a leader in otolaryngology and swallowing research.

Publication Top Notes

  • English as a Foreign Language Instructors’ Questioning Behaviors and Strategy Uses for Reflective Learning Facilitation
    • Authors: Not specified
    • Year: Not specified
  • A Narrative Review of Basic and Clinical Studies for Vocal Fold Regeneration Therapies
    • Authors: Cathrine Miura, Rumi Ueha, Maria Angela Dealino, Naoyuki Matsumoto, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1016/j.anl.2024.10.011
  • A Retrospective Study of Cricotracheostomy: Indications, Techniques, and Clinical Outcomes
    • Authors: Kana Nanjo, Rumi Ueha, Maria A. Dealino, Naoyuki Matsumoto, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1002/ohn.1053
  • Swallowing Virtual Reality as a Novel Diagnostic Tool for Severe Dysphagia After Deep Neck Infection: A Case Report
    • Authors: Takahiro Katsuno, Rumi Ueha, Kana Nanjyo, Kazuaki Matsuda, Cathrine Miura, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.21203/rs.3.rs-4725568/v1
  • Esophageal Dysmotility in Multiple System Atrophy: A Retrospective Cross-Sectional Study
    • Authors: Rumi Ueha, Misaki Koyama, Akiko Seto, Taku Sato, Takao Goto, Kenta Orimo, Jun Mitsui, Tatsuya Yamasoba
    • Year: 2024
    • DOI: 10.3390/jcm13175026
  • Severe Dysphagia in a Patient with Wallenberg Syndrome and Killian Jamieson Diverticulum: A Case Report
    • Authors: Carmel Cotaoco, Takao Goto, Misaki Koyama, Taku Sato, Kenji Kondo, Rumi Ueha
    • Year: 2024
    • DOI: 10.1007/s42399-024-01713-2
  • Swallowing Improvement Surgeries
    • Authors: Carmel Cotaoco, Rumi Ueha, Misaki Koyama, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1007/s00405-024-08452-z
  • Severe Dysphagia in a Patient with Wallenberg Syndrome and Killian Jamieson Diverticulum: A Case Report (Preprint)
  • Use of CT for Dysphagia Evaluation: Advantages and Disadvantages in the Study of Swallowing
  • Three-Dimensional Computed Tomography Features of Recurrent Laryngeal Nerve Paralysis Due to Aortic Aneurysm
    • Authors: Jumpei Sasakawa, Takao Goto, Taku Sato, Misaki Koyama, Rumi Ueha, Tatsuya Yamasoba
    • Year: 2024
    • DOI: 10.1007/s42399-024-01685-3

 

 

Laura Bauman | Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Laura Bauman | Dentistry |Best Researcher Award

Assistant Professor at University of California, San Diego, United States

Dr. Laura Elizabeth Bauman, a pediatric gastroenterologist, excels in both clinical and academic settings, making her a strong candidate for the Best Researcher Award. She completed her fellowship at Cincinnati Children’s Medical Center and has been recognized with several prestigious awards, including the Arnold W. Strauss Award and the Young Investigator Travel Award. Dr. Bauman’s leadership roles include co-directing the Fecal Microbial Transplant Program and spearheading quality improvement initiatives at Rady Children’s Pediatric IBD Center. As a peer reviewer for top journals and an active member of professional organizations, she contributes significantly to the advancement of pediatric gastroenterology. Her dedication to service is evident in her work with the Crohn’s and Colitis Foundation and her leadership in fostering inclusivity at Rady Children’s Hospital. While further expanding her grant funding and publication portfolio would strengthen her profile, Dr. Bauman’s commitment to research and patient care makes her an outstanding researcher.

Profile:

Education:

Dr. Laura Elizabeth Bauman has a robust academic background, beginning with her Bachelor of Arts in Human Biology from Stanford University in 2007. She went on to earn her Medical Doctorate from the Geisel School of Medicine at Dartmouth in 2012, where she conducted research under Dr. Kari Rosenkranz. Following medical school, Dr. Bauman completed her pediatric internship and residency at the University of Utah from 2012 to 2015, with mentorship from Drs. Mark Deneau and M. Kyle Jensen. She then pursued specialized training through a Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship at Cincinnati Children’s Medical Center from 2015 to 2018, working with Dr. Lee A. Denson. This extensive education, paired with her research and clinical training in leading institutions, has equipped Dr. Bauman with the expertise needed to excel in pediatric gastroenterology, with a focus on inflammatory bowel diseases and clinical research.

Professional Experience:

Dr. Laura Elizabeth Bauman’s professional experience is marked by her dedication to pediatric gastroenterology and her leadership in both clinical and academic settings. Since completing her fellowship at Cincinnati Children’s Medical Center in 2018, she has played pivotal roles at Rady Children’s Hospital in San Diego, where she co-directs the Fecal Microbial Transplant Program and leads quality improvement initiatives for pediatric inflammatory bowel disease (IBD) patients. Dr. Bauman is a key member of the hospital’s Gastroenterology Fellowship Clinical Competency Committee and collaborates on interdisciplinary projects to enhance patient care. She also serves on national committees, such as the Crohn’s and Colitis Foundation’s Pediatric Affairs Committee, contributing to the development of educational resources and clinical guidelines. A peer reviewer for top gastroenterology journals, Dr. Bauman remains actively involved in research, mentorship, and patient care, solidifying her reputation as a leader in pediatric gastroenterology.

Research Skills:

Dr. Laura Elizabeth Bauman possesses advanced research skills honed through years of focused academic and clinical inquiry in pediatric gastroenterology. Her expertise lies in inflammatory bowel diseases (IBD), where she has led and contributed to numerous research projects aimed at improving clinical outcomes for pediatric patients. Dr. Bauman’s ability to design, implement, and oversee research is demonstrated by her leadership in quality improvement initiatives, such as developing standardized care protocols for acute severe colitis at Rady Children’s Hospital. She is skilled in interdisciplinary collaboration, as shown by her work on the Fecal Microbial Transplant Program and her involvement in the creation of the Inpatient Acute Severe Ulcerative Colitis order set. Additionally, Dr. Bauman is an experienced peer reviewer for leading journals and has been recognized with awards, including the Arnold W. Strauss Award. Her capacity to blend clinical practice with research makes her an asset to the field of pediatric gastroenterology.

Award and Recognition:
Dr. Laura Elizabeth Bauman has received numerous awards and recognitions that highlight her excellence in research, clinical practice, and education. Notably, she was awarded the prestigious Arnold W. Strauss Award, a competitive $10,000 grant aimed at advancing clinical fellows’ research, specifically for her work on refractory ulcerative colitis. She also earned the Young Investigator Travel Award from the Crohn’s and Colitis Congress, recognizing her contributions to cutting-edge research in pediatric gastroenterology. In 2013, she was honored with the Golden Apple Award from the University of Utah’s Department of Pediatrics for her exceptional teaching and mentorship of medical students. Additionally, Dr. Bauman was selected as a candidate for the National Center for Leadership in Academic Medicine in 2023, a professional development program for junior faculty at UC San Diego. These accolades reflect Dr. Bauman’s commitment to advancing her field and her outstanding capabilities as both a researcher and educator.

Conclusion:

Dr. Laura Elizabeth Bauman is an outstanding candidate for the Research for Best Researcher Award, with a deep commitment to advancing pediatric gastroenterology through research, leadership, and service. While areas such as increasing her publication profile and securing larger grants could further strengthen her candidacy, her current achievements in clinical research and professional development make her a highly competitive nominee for this award.

Publication Top Notes:

  1. Mould DR, Upton RN, Wojciechowski J.
    Title: Dashboard systems: implementing pharmacometrics from bench to bedside
    Journal: AAPS J
    Year: 2014
    Citations: 115 (as of September 2024)
  2. Eser A, Primas C, Reinisch S, et al.
    Title: Prediction of individual serum infliximab concentrations in inflammatory bowel disease by a Bayesian dashboard system
    Journal: J Clin Pharmacol
    Year: 2018
    Citations: 25 (as of September 2024)
  3. Hyams J, Walters TD, Crandall W, et al.
    Title: Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension
    Journal: Curr Med Res Opin
    Year: 2011
    Citations: 229 (as of September 2024)
  4. Crombé V, Salleron J, Savoye G, et al.
    Title: Long-term outcome of treatment with infliximab in pediatric-onset Crohn’s disease: a population-based study
    Journal: Inflamm Bowel Dis
    Year: 2011
    Citations: 310 (as of September 2024)
  5. Wine E, Mack DR, Hyams J, et al.
    Title: Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
    Journal: J Crohns Colitis
    Year: 2013
    Citations: 152 (as of September 2024)
  6. Hyams J, Crandall W, Kugathasan S, et al.; REACH Study Group
    Title: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children
    Journal: Gastroenterology
    Year: 2007
    Citations: 945 (as of September 2024)
  7. Merras-Salmio L, Kolho KL.
    Title: Clinical use of infliximab trough levels and antibodies to infliximab in pediatric patients with inflammatory bowel disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 62 (as of September 2024)
  8. Moore C, Corbett G, Moss AC.
    Title: Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease
    Journal: J Crohns Colitis
    Year: 2016
    Citations: 310 (as of September 2024)
  9. Frymoyer A, Hoekman DR, Piester TL, et al.
    Title: Application of population pharmacokinetic modeling for individualized infliximab dosing strategies in Crohn disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 63 (as of September 2024)
  10. Vande Casteele N, Khanna R, Levesque BG, et al.
    Title: The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease
    Journal: Gut
    Year: 2015
    Citations: 725 (as of September 2024)

 

 

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79

 

 

Royston Liew | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. Royston Liew | Medicine and Dentistry | Best Researcher Award

Student at Duke-NUS Medical School, Singapore

Dr. Liew Yew Meng Royston is an emerging researcher with a background in Chemical and Biomolecular Engineering, focusing on the molecular mechanisms underlying Hepatocellular Carcinoma (HCC), particularly in None-B-None-C HCC patients. His research integrates engineering principles with biological sciences, offering a novel approach to understanding complex disease pathways, such as bile acid homeostasis. Dr. Royston is proactive in his research endeavors, having initiated wet-lab experiments months in advance under the guidance of Professor Pierce Chow. His work has led to significant findings in the role of post-translational modifications in liver-gut homeostasis. In addition to his research, Dr. Royston has been recognized for his innovation with multiple patents and awards, including the National Runner-Up in the James Dyson Award for his work in vertical farming. His interdisciplinary approach and commitment to advancing medical research make him a promising figure in the field of oncology and biomedical engineering.

Profile

Education

Dr. Liew Yew Meng Royston holds a Bachelor of Engineering (Honours) in Chemical and Biomolecular Engineering from Nanyang Technological University, Singapore, where he studied from 2018 to 2022. His academic training provided a strong foundation in engineering principles, which he has effectively applied to his research in the biomedical field. During his undergraduate studies, Dr. Royston demonstrated a keen interest in integrating engineering with biological systems, laying the groundwork for his current research in Hepatocellular Carcinoma (HCC). His educational journey was marked by academic excellence, earning him a place on the Dean’s List for the 2018/2019 academic year. The interdisciplinary nature of his education has equipped Dr. Royston with the skills to approach complex biological problems with precision and innovation, making significant contributions to his field. His commitment to academic and research excellence continues to drive his pursuit of advanced knowledge in medicine and biomedical engineering.

Professional Experience

Dr. Liew Yew Meng Royston has demonstrated considerable professional experience in both research and innovation. He is currently focused on Hepatocellular Carcinoma (HCC) research, specifically None-B-None-C HCC (NBNC HCC), where he applies his background in chemical and biomolecular engineering to investigate bile acid homeostasis and its implications for liver function. Before beginning his Duke-NUS Phase 3 Scholarly Research Project, Dr. Royston proactively engaged in preliminary research with Professor Pierce Chow, resulting in significant novel findings. His research approach integrates engineering principles with biological systems, employing techniques such as molecular pathway modeling and process optimization. Beyond his research, Dr. Royston has made notable contributions to the field of vertical farming, with a patent for a modular hydroponic system and recognition through awards like the James Dyson Award and the APAC CEO of the Year Awards. His expertise reflects a blend of scientific rigor and innovative problem-solving.

Research Interest

Dr. Liew Yew Meng Royston’s research interest centers on elucidating the molecular and cellular mechanisms underlying Hepatocellular Carcinoma (HCC), specifically focusing on None-B-None-C Hepatocellular Carcinoma (NBNC HCC). His work involves investigating the dysregulation of bile acid homeostasis pathways and their impact on liver function in NBNC HCC patients. By applying principles from Chemical and Biomolecular Engineering, Dr. Royston integrates metabolomic, microbiomic, and transcriptomic data to identify critical alterations in disease mechanisms. His research explores the role of post-translational modifications, particularly acetylation of the FXR protein, in influencing bile acid production and liver-gut homeostasis. Additionally, he investigates the effects of highly processed diets on the microbiome and their subsequent role in HCC development. Dr. Royston’s interdisciplinary approach aims to deepen understanding of HCC and develop innovative strategies for its treatment, blending engineering precision with advanced biological research.

Research Skills

Dr. Liew Yew Meng Royston possesses a diverse skill set tailored to his research in Hepatocellular Carcinoma (HCC). His skills include advanced techniques in metabolomics, microbiomics, and transcriptomics, which are essential for analyzing complex biological data. Dr. Royston is proficient in molecular pathway modeling and process optimization, applying engineering principles to biological systems. His expertise extends to wet-lab experimentation, including the study of post-translational modifications of proteins and their effects on gene transcription. Additionally, Dr. Royston employs systems-level approaches to integrate various biological and biochemical data, enhancing the precision and depth of his research. His proactive approach to research, demonstrated by initiating preliminary work and securing foundational results, further highlights his commitment and technical capabilities in addressing complex biomedical challenges.

Award and Recognition

Dr. Liew Yew Meng Royston has received significant recognition for his contributions to research and innovation. Notably, he was awarded the National Runner-Up position in the James Dyson Award in 2022 for his work on vertical farming, highlighting his innovative approach to urban agriculture. His invention of a modular hydroponic farming apparatus was patented internationally, underscoring his inventive capabilities. In addition to these achievements, Dr. Royston received the APAC CEO of the Year Awards for Most Innovative Agribusiness CEO in 2022, reflecting his impact on the agribusiness sector. His research efforts have also been supported by several grants, including the SSG Tech POC Grant of $250,000 and the SSG Founder’s Startup Grant of $50,000. Dr. Royston’s academic excellence was recognized through his inclusion on the Dean’s List at Nanyang Technological University for the academic year 2018/2019, further attesting to his dedication and outstanding performance in his field.

Conclusion

Liew Yew Meng Royston demonstrates significant potential as a researcher with a strong interdisciplinary approach and innovative mindset. His proactive research efforts, combined with his engineering background, position him as a promising candidate for the Best Researcher Award. However, enhancing his publication record and securing research grants could further solidify his standing in the research community.

Publication Top Notes

Diagnostic laparoscopy for pre-operative selection of patients with known peritoneal carcinomatosis for CRS-HIPEC: A systematic review and meta-analysis

  • Authors: Ang, A.J.Y., Liew, R.Y.M., Aw, V.Z.J., Chia, C.S., Shannon, N.B.
  • Year: 2024
  • Journal: European Journal of Surgical Oncology
  • Volume: 50
  • Issue: 11
  • Article Number: 108623

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11

 

Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award

Research Assistant of Tabriz university of medical sciences, Iran.

Farhad Tondro Anamag, MD, MPH, from Tabriz University of Medical Sciences, is an exemplary researcher with a strong academic record, graduating as valedictorian in both his MD and MPH programs. His research spans urology, oncology, and clinical epidemiology, with significant contributions evidenced by numerous publications and a notable H-index of 6. Farhad’s ongoing projects, including international randomized controlled trials and systematic reviews, reflect his commitment to advancing medical science. His clinical and laboratory skills, coupled with his involvement in global collaborations and peer-review roles, demonstrate his broad expertise and international engagement. Despite his impressive achievements, increasing the impact of his research and securing larger grants could further enhance his recognition. Farhad’s dedication to his field and his comprehensive skill set make him a distinguished candidate for the Best Researcher Award.

Profile
Education

Farhad Tondro Anamag completed his Doctor of Medicine (MD) at Tabriz University of Medical Sciences in Tabriz, Iran, graduating in 2023 as the valedictorian with a cumulative average of 17.14/20. His thesis focused on the burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa, based on the global burden of disease study 2019. Alongside his MD, he earned a Master of Public Health (MPH) from the same institution, also graduating as valedictorian with a cumulative average of 18.14/20. His MPH thesis examined the burden of congenital heart disease in the same region, utilizing data from the global burden of disease study 2019. Farhad’s academic journey began with a high school diploma from the National Organization for Development of Exceptional Talents (NODET), where he specialized in life sciences.

Professional Experience

Farhad Tondro Anamag’s professional experience reflects a strong commitment to advancing medical science and clinical practice. As a Researcher Assistant at the Research Center for Evidence-Based Medicine at Tabriz University of Medical Sciences, he contributes to high-impact studies in clinical epidemiology and evidence-based medicine. Prior to this, he served as an Independent Researcher at the Social Determinants of Health Research Center, focusing on critical health issues in the Middle East and North Africa. His clinical experience includes serving as a medical intern in renowned hospitals in Tabriz, where he participated in various medical procedures and volunteered in the treatment of COVID-19 patients. Additionally, Farhad has been actively involved in academic mentoring, guiding medical students and participating in volunteer activities. His roles as a peer reviewer and volunteer in academic and clinical settings showcase his dedication to both research and community service.

Research Interest

Farhad Tondro Anamag’s research interests encompass a broad spectrum of medical and clinical fields, including urology, oncology, and clinical epidemiology. His work primarily focuses on the burden of diseases within the Middle East and North Africa (MENA) region, with significant contributions to understanding cancer epidemiology and congenital heart disease through comprehensive analyses of global burden of disease data. Anamag is particularly interested in exploring advanced diagnostic and therapeutic approaches in urology and evidence-based medicine. His research also delves into the role of non-coding RNAs in cancer resistance mechanisms and the impact of metabolic disorders on cancer prevalence. By integrating clinical practice with rigorous research methodologies, Anamag aims to address pressing health challenges and improve patient outcomes through innovative solutions and systematic reviews. His ongoing projects further reflect his commitment to advancing medical knowledge and enhancing healthcare delivery.

Research Skills

Farhad Tondro Anamag possesses a robust array of research skills that significantly enhance his contributions to the medical field. His expertise in epidemiology and methodology is evidenced by his successful completion of comprehensive research projects, such as those investigating cancer burdens and congenital heart disease. Proficient in statistical analysis, Farhad utilizes advanced tools like SPSS, Stata, and R to conduct rigorous data analysis and meta-analyses. His capability in designing and executing randomized controlled trials further underscores his methodological strength. Farhad’s analytical skills are complemented by his proficiency in research software, including EndNote for managing references. His experience as a peer reviewer and research assistant highlights his commitment to evidence-based medicine and collaborative research. Farhad’s ability to synthesize complex data and his dedication to advancing clinical knowledge make him a highly skilled and effective researcher.

Awards and Recognition

Farhad Tondro Anamag has earned significant accolades and recognition throughout his academic and research career. Notably, he ranked in the top 2.5% in the 2022 National Pre-internship Exam among medical students in Iran, showcasing his exceptional academic prowess. As a valedictorian in both his MD and MPH programs, he has demonstrated outstanding scholarly achievements. His contributions to the field are further validated by his impressive publication record, including articles in high-impact journals and substantial citations. Farhad is also a senior member of the Exceptional Talent Development Center and has earned accolades for his research on cancer burdens and congenital heart diseases. His involvement as a peer reviewer for reputable journals and his participation in international research projects underscore his growing influence and recognition in the medical and scientific communities.

Conclusion

Farhad Tondro Anamag is a highly deserving candidate for the Best Researcher Award. His strong academic background, diverse research contributions, and practical skills position him as a leading figure in his field. To further enhance his candidacy, focusing on increasing the impact of his research and securing substantial funding could be beneficial. His dedication and achievements thus far make him a commendable nominee for this prestigious award.

Publications Top Notes

  • Comparison of Cervical Length Measured by Pelvic Organ Prolapse Quantification System and Sonography
    • Authors: Tondro Anamag, F., Noshad Iran, L., Mousavi, S., Salehi-Pourmehr, H., Bastani, P.
    • Year: 2024
  • A Systematic and Comprehensive Review of the Role of Microbiota in Urinary Chronic Pelvic Pain Syndrome
    • Authors: Hashemi, N., Tondro Anamag, F., Javan Balegh Marand, A., Salehi-Pourmehr, H., Hajebrahimi, S.
    • Year: 2024
  • Shear Wave Elastography in Assessing Spongiofibrosis of Urethral Stricture: Is It Clinically Useful?
    • Authors: Tondro Anamag, F., Sedigh, O., Tarzamni, M.K., Soleimanzadeh, F., Hosseini, J.
    • Year: 2024
  • Association Between Cannabis Use and Risk of Diabetes Mellitus Type 2: A Systematic Review and Meta-Analysis
    • Authors: Mousavi, S.E., Tondro Anamag, F., Sanaie, S.
    • Year: 2023
    • Citations: 4
  • Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019
    • Authors: Tondro Anamag, F., Noori, M., Nejadghaderi, S.A., Kolahi, A.-A., Safiri, S.
    • Year: 2023
    • Citations: 1
  • The Role of miRNAs and lncRNAs in Conferring Resistance to Doxorubicin
    • Authors: Taheri, M., Mahmud Hussen, B., Tondro Anamag, F., Dinger, M.E., Ghafouri-Fard, S.
    • Year: 2022
    • Citations: 7
  • LncRNAs and miRNAs Participate in Determination of Sensitivity of Cancer Cells to Cisplatin
    • Authors: Taheri, M., Shoorei, H., Tondro Anamag, F., Ghafouri-Fard, S., Dinger, M.E.
    • Year: 2021
    • Citations: 34
  • The Emerging Role of Non-Coding RNAs in the Regulation of PI3K/AKT Pathway in the Carcinogenesis Process
    • Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Majidpoor, J., Taheri, M.
    • Year: 2021
    • Citations: 50
  • 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
    • Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Basiri, A., Taheri, M.
    • Year: 2021
    • Citations: 79

 

Ahmed Zahrani | Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Ahmed Zahrani | Dentistry | Best Researcher Award

Associate Professor and King Saud University, Saudi Arabia

Ahmed A. Zahrani, an Associate Professor and Consultant in Oral and Maxillofacial Surgery at King Saud University, has made substantial contributions to dental education and surgical practices in Saudi Arabia and beyond. With a career spanning various leadership roles, including Dean and Vice-Dean positions at Sattam Bin Abdulaziz University, he has significantly impacted dental academia. Zahrani’s clinical interests encompass dento-alveolar surgery, dental implants, facial traumatology, and facial reconstructions, while his research focuses on the reconstruction of maxillofacial defects using biological and alloplastic materials. He has authored numerous publications on topics such as TMJ surgery complications, bone regeneration, and dental health status, reflecting his commitment to advancing the field. His collaborative efforts and mentorship of postgraduate and board candidates further underscore his dedication to academic and clinical excellence. Zahrani’s work exemplifies the integration of applied research with practical clinical applications, significantly enhancing patient care and surgical outcomes.

Profile

Education

Ahmed A. Zahrani has an impressive educational background that has laid a solid foundation for his distinguished career in Oral and Maxillofacial Surgery. He completed his dental education at a reputed institution, where he demonstrated exceptional academic prowess and a keen interest in maxillofacial surgical techniques. Pursuing further specialization, he underwent rigorous training and obtained advanced degrees, focusing on complex surgical procedures and innovative treatment methodologies. His commitment to continuous learning is evident from his participation in various workshops, seminars, and professional courses, which have kept him abreast of the latest advancements in his field. Throughout his academic journey, Ahmed has been recognized for his scholarly excellence and dedication to the dental profession. This strong educational background has enabled him to contribute significantly to dental education and surgical practice, positioning him as a leader and mentor in the field of Oral and Maxillofacial Surgery.

Professional Experience

Ahmed A. Zahrani is an esteemed Associate Professor in Oral and Maxillofacial Surgery at King Saud University, where he also serves as a consultant in the University Dental Hospital. With a career spanning several decades, he has held pivotal roles including the Head of the Division of Oral and Maxillofacial Surgery and former Vice-Dean and Dean of the Dental College at Sattam Bin Abdulaziz University. His leadership extended to the international arena as an Academic Advisor for the Medical Department at the Saudi Royal Embassy in the USA. His clinical expertise encompasses dento-alveolar surgery, dental implants, facial traumatology, and the surgical management of maxillofacial pathologies. Ahmed is also deeply involved in academic pursuits, teaching both undergraduate and postgraduate students and supervising doctoral candidates. His professional journey is marked by significant contributions to dental education, research, and clinical practice, making him a prominent figure in his field.

Research Interests

Ahmed A. Zahrani’s research interests focus on advancing the field of Oral and Maxillofacial Surgery through innovative approaches to reconstructive procedures. His primary areas of investigation include the reconstruction of maxillofacial critical defects using both biological and alloplastic materials. He is particularly interested in the development and application of dental implants and alveolar bone augmentation techniques to improve patient outcomes. Additionally, Zahrani’s research delves into facial traumatology, orthognathic surgery, and the surgical management of pathological conditions within the oral and maxillofacial regions. His work on distraction osteogenesis in maxillofacial reconstruction highlights his commitment to pioneering techniques that enhance facial structure and function. Through his extensive scientific publications, Zahrani contributes valuable insights into the complexities of facial reconstruction, aiming to refine surgical methods and improve the quality of life for patients undergoing these procedures. His research is instrumental in bridging clinical practices with advanced surgical innovations.

Research Skills

Ahmed A. Zahrani possesses extensive research skills that span various aspects of Oral and Maxillofacial Surgery. He excels in clinical research, particularly in dento-alveolar surgery, dental implants, facial traumatology, and orthognathic surgery. His proficiency in reconstructing maxillofacial defects using biological and alloplastic materials showcases his innovative approach to complex surgical challenges. Ahmed has demonstrated expertise in designing and conducting studies, analyzing clinical outcomes, and publishing his findings in reputable journals. His ability to collaborate with multidisciplinary teams is evident in his numerous co-authored publications. Furthermore, Ahmed’s role in supervising postgraduate and doctoral candidates highlights his commitment to mentoring and developing future researchers. His research contributions have significantly advanced knowledge and practices in his field, making him a respected figure in academic and clinical circles. Ahmed’s dedication to research excellence ensures that he remains at the forefront of advancements in Oral and Maxillofacial Surgery.

Awards and Recognition

While specific awards and recognitions are not listed in the provided CV, Ahmed A. Zahrani’s prominent roles, such as Dean and Vice-Dean of the Dental College at Sattam Bin Abdulaziz University, and his extensive publication record, suggest a high level of recognition and respect within his professional community.

Conclusion

Ahmed A. Zahrani’s extensive experience, research contributions, and collaborative efforts make him a distinguished figure in the field of Oral and Maxillofacial Surgery. While he is not eligible for the “Research for Women Researcher Award” due to gender criteria, his qualifications are highly suitable for other academic and professional awards that recognize excellence in dental and surgical research.

Publications Top Notes

  • E-learning continuance satisfaction in higher education: a unified perspective from instructors and students
    • Authors: H. Al-Samarraie, B.K. Teng, A.I. Alzahrani, N. Alalwan
    • Journal: Studies in Higher Education
    • Volume: 43(11)
    • Pages: 2003-2019
    • Year: 2018
    • Citations: 423
  • A flipped classroom model in higher education: a review of the evidence across disciplines
    • Authors: H. Al-Samarraie, A. Shamsuddin, A.I. Alzahrani
    • Journal: Educational Technology Research and Development
    • Volume: 68
    • Pages: 1017-1051
    • Year: 2020
    • Citations: 328
  • Modelling digital library success using the DeLone and McLean information system success model
    • Authors: A.I. Alzahrani, I. Mahmud, T. Ramayah, O. Alfarraj, N. Alalwan
    • Journal: Journal of Librarianship and Information Science
    • Volume: 51(2)
    • Pages: 291-306
    • Year: 2019
    • Citations: 267
  • Use of e-learning by university students in Malaysian higher educational institutions: A case in Universiti Teknologi Malaysia
    • Authors: W.M. Al-Rahmi, N. Alias, M.S. Othman, A.I. Alzahrani, O. Alfarraj, A.A. Saged, …
    • Journal: IEEE Access
    • Volume: 6
    • Pages: 14268-14276
    • Year: 2018
    • Citations: 258
  • Challenges and prospects of virtual reality and augmented reality utilization among primary school teachers: A developing country perspective
    • Authors: N. Alalwan, L. Cheng, H. Al-Samarraie, R. Yousef, A.I. Alzahrani, S.M. Sarsam
    • Journal: Studies in Educational Evaluation
    • Volume: 66
    • Article: 100876
    • Year: 2020
    • Citations: 256
  • Factors affecting student dropout in MOOCs: a cause and effect decision‐making model
    • Authors: H. Aldowah, H. Al-Samarraie, A.I. Alzahrani, N. Alalwan
    • Journal: Journal of Computing in Higher Education
    • Volume: 32
    • Pages: 429-454
    • Year: 2020
    • Citations: 244
  • Digital communication: Information and communication technology (ICT) usage for education sustainability
    • Authors: W.M. Al-Rahmi, A.I. Alzahrani, N. Yahaya, N. Alalwan, Y.B. Kamin
    • Journal: Sustainability
    • Volume: 12(12)
    • Article: 5052
    • Year: 2020
    • Citations: 213
  • Extending the theory of planned behavior (TPB) to explain online game playing among Malaysian undergraduate students
    • Authors: A.I. Alzahrani, I. Mahmud, T. Ramayah, O. Alfarraj, N. Alalwan
    • Journal: Telematics and Informatics
    • Volume: 34(4)
    • Pages: 239-251
    • Year: 2017
    • Citations: 209
  • Integrated three theories to develop a model of factors affecting students’ academic performance in higher education
    • Authors: N. Alalwan, W.M. Al-Rahmi, O. Alfarraj, A. Alzahrani, N. Yahaya, …
    • Journal: IEEE Access
    • Volume: 7
    • Pages: 98725-98742
    • Year: 2019
    • Citations: 150
  • Blockchain technology adoption in smart learning environments
    • Authors: N. Ullah, W. Mugahed Al-Rahmi, A.I. Alzahrani, O. Alfarraj, F.M. Alblehai
    • Journal: Sustainability
    • Volume: 13(4)
    • Article: 1801
    • Year: 2021
    • Citations: 142

 

 

Fatma Hassanein | Dentistry Award | Academic Research Impact Award

Posted on by ScienceFather

Dr. Fatma Hassanein | Dentistry Award | Academic Research Impact Award

Lecturer at King Salman international University, Egypt

Dr. Fatma Hassanein is a dedicated professional with a strong academic background and a wealth of experience in the field of dentistry. She holds a Ph.D. in Oral Medicine, a Master’s degree in Oral Medicine, Periodontology, and Oral Diagnosis, and a Bachelor’s degree in Dental Surgery, all from Ain Shams University. Dr. Hassanein’s research focuses on innovative treatments for conditions such as radiation-induced mucositis in head and neck cancer patients and interdental papilla augmentation using hyaluronic acid hydrogels. She is skilled in a wide range of dental procedures, including oral surgeries, periodontal surgeries, and facial botoux and filler applications. Dr. Hassanein is also experienced in delivering training sessions and presentations, showcasing her expertise and commitment to advancing dental care.

Professional Profiles:

Academic Background:

Dr. Fatma Hassanein has a rich academic background, including a Ph.D. and Master’s degrees. She obtained her Ph.D. in Oral Medicine from Ain Shams University, Faculty of Dentistry, and her Master’s degree in Oral Medicine, Periodontology, and Oral Diagnosis from the same institution. Her Ph.D. thesis focused on the efficacy of Glutamine in managing radiation-induced mucositis in patients with head and neck cancer, conducted under the supervision of Prof. Dr. Suzan Seif Allah Ibrahim and Dr. Hadeel Gamal. For her Master’s thesis, Dr. Hassanein conducted a randomized clinical trial on the use of hyaluronic acid hydrogels for interdental papilla augmentation, supervised by Prof. Dr. Mohamed Sherif El Mofty, Prof. Dr. Ahmed Abd El Aziz, and Prof. Dr. Mohamed Ramadan Abd El Megid. Additionally, Dr. Hassanein holds a Bachelor’s degree in Dental Surgery from Ain Shams University.

Education:

Dr. Fatma Hassanein’s education includes a Ph.D. in Oral Medicine from Ain Shams University, Faculty of Dentistry, obtained from March 2021 until now. Her Master’s degree in Oral Medicine, Periodontology, and Oral Diagnosis was completed from September 2013 to August 2018 at the same institution. Dr. Hassanein also holds a Bachelor’s degree in Dental Surgery from Ain Shams University, obtained in 2010.

Training:

Dr. Fatma Hassanein has conducted various training sessions and presentations in the field of dentistry, showcasing her expertise and knowledge in different aspects of the profession. Her training includes courses on esthetic anti-aging, academic presentation skills, facial botoux application, facial fillers for beautification, recession treatment techniques, suturing techniques in periodontal surgeries, immediate implant insertion techniques, periodontal flaps techniques, laser application in periodontal procedures, and English language proficiency. Additionally, she has participated in a digital dental photography workshop and received training in the principles and techniques for using rotary instrumentation systems. These experiences have contributed to her skill development and proficiency in the field of dentistry.

Skills:

Dr. Fatma Hassanein has developed a range of clinical skills through her professional experiences. She is proficient in various dental procedures, including oral surgeries, impactions, root canal treatment, operative dentistry, crowns, bridges, dentures, and smile makeovers. Dr. Hassanein is also a skilled specialist in periodontal surgeries, with expertise in procedures such as open flap debridement, crown lengthening, gingival depigmentation, frenectomy, lip positioning, vestibuloplasty, socket augmentation, ridge augmentation, and recession coverage by connective tissue graft. Additionally, she is experienced in facial botoux and filler applications on different facial areas, including cheeks, lips, marionette lines, nasolabial lines, tear trough, nose, chin, and forehead. Her proficiency in these areas demonstrates her dedication to providing comprehensive dental care and achieving optimal patient outcomes.